Eligo Bioscience

Eligo Bioscience company information, Employees & Contact Information

Explore related pages

Related company profiles:

Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.

Company Details

Employees
43
Founded
-
Address
Rue Du Faubourg St Jacques, Paris,il De France 75014,france
Email
co****@****nce.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Paris, Il de France
Looking for a particular Eligo Bioscience employee's phone or email?

Eligo Bioscience Questions

News

Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology - PR Newswire

Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology PR Newswire

Breaking: Eligo Bioscience Reports First-Ever in Vivo Microbiome Base Editing - CRISPR Medicine News

Breaking: Eligo Bioscience Reports First-Ever in Vivo Microbiome Base Editing CRISPR Medicine News

Eligo Bioscience secures grant to advance topical gene delivery platform - Pharmaceutical Technology

Eligo Bioscience secures grant to advance topical gene delivery platform Pharmaceutical Technology

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines - Business Wire

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines Business Wire

Eligo Bioscience Achieves Breakthrough in In Vivo Bacterial Genome Editing - SynBioBeta

Eligo Bioscience Achieves Breakthrough in In Vivo Bacterial Genome Editing SynBioBeta

French Biotech Gets $20M to Treat the Microbiome with CRISPR Nanobots - Labiotech.eu

French Biotech Gets $20M to Treat the Microbiome with CRISPR Nanobots Labiotech.eu

In situ targeted base editing of bacteria in the mouse gut - Nature

In situ targeted base editing of bacteria in the mouse gut Nature

CRISPR Next Frontier: In Vivo Editing of the Microbiome. Interview With Xavier Duportet, Eligo Bioscience - CRISPR Medicine News

CRISPR Next Frontier: In Vivo Editing of the Microbiome. Interview With Xavier Duportet, Eligo Bioscience CRISPR Medicine News

Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome - PR Newswire

Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome PR Newswire

Eligo Bioscience receives EUR 2 Million from Seventure Partners to develop smart antibiotics - Institut Pasteur

Eligo Bioscience receives EUR 2 Million from Seventure Partners to develop smart antibiotics Institut Pasteur

Eligo raises $20M to take bacteria-killing CRISPR drug into clinic - Fierce Biotech

Eligo raises $20M to take bacteria-killing CRISPR drug into clinic Fierce Biotech

Eligo Bioscience Announces Broadest Prokaryotic CRISPR Patent Ever Granted - CRISPR Medicine News

Eligo Bioscience Announces Broadest Prokaryotic CRISPR Patent Ever Granted CRISPR Medicine News

Top Eligo Bioscience Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant